nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—CYP2C19—Ifosfamide—germ cell cancer	0.132	0.367	CbGbCtD
Gliclazide—CYP2C9—Ifosfamide—germ cell cancer	0.109	0.305	CbGbCtD
Gliclazide—ALB—Methotrexate—germ cell cancer	0.0641	0.179	CbGbCtD
Gliclazide—CYP2C9—Cisplatin—germ cell cancer	0.0533	0.149	CbGbCtD
Gliclazide—CYP2C9—cardial valve—germ cell cancer	0.0254	0.188	CbGeAlD
Gliclazide—VEGFA—Glypican 1 network—TDGF1—germ cell cancer	0.00838	0.136	CbGpPWpGaD
Gliclazide—CYP2C19—urine—germ cell cancer	0.00708	0.0523	CbGeAlD
Gliclazide—VEGFA—trigeminal ganglion—germ cell cancer	0.00624	0.0461	CbGeAlD
Gliclazide—CYP2C9—urine—germ cell cancer	0.00549	0.0405	CbGeAlD
Gliclazide—VEGFA—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.00531	0.0861	CbGpPWpGaD
Gliclazide—VEGFA—NOTCH1 regulation of human endothelial cell calcification—ALPL—germ cell cancer	0.00496	0.0806	CbGpPWpGaD
Gliclazide—VEGFA—telencephalon—germ cell cancer	0.0049	0.0362	CbGeAlD
Gliclazide—VEGFA—decidua—germ cell cancer	0.00464	0.0343	CbGeAlD
Gliclazide—VEGFA—uterus—germ cell cancer	0.00406	0.03	CbGeAlD
Gliclazide—VEGFA—pituitary gland—germ cell cancer	0.00399	0.0295	CbGeAlD
Gliclazide—ABCC8—brainstem—germ cell cancer	0.00364	0.0269	CbGeAlD
Gliclazide—VEGFA—adrenal gland—germ cell cancer	0.00356	0.0263	CbGeAlD
Gliclazide—VEGFA—bone marrow—germ cell cancer	0.00345	0.0255	CbGeAlD
Gliclazide—VEGFA—spinal cord—germ cell cancer	0.00343	0.0253	CbGeAlD
Gliclazide—VEGFA—female gonad—germ cell cancer	0.00332	0.0245	CbGeAlD
Gliclazide—ABCC8—telencephalon—germ cell cancer	0.00323	0.0238	CbGeAlD
Gliclazide—VEGFA—testis—germ cell cancer	0.00295	0.0218	CbGeAlD
Gliclazide—VEGFA—cerebellum—germ cell cancer	0.00272	0.0201	CbGeAlD
Gliclazide—ABCC8—pituitary gland—germ cell cancer	0.00263	0.0194	CbGeAlD
Gliclazide—KCNJ11—adrenal gland—germ cell cancer	0.00255	0.0188	CbGeAlD
Gliclazide—ABCC8—medulla oblongata—germ cell cancer	0.00254	0.0187	CbGeAlD
Gliclazide—KCNJ11—female gonad—germ cell cancer	0.00238	0.0176	CbGeAlD
Gliclazide—ABCC8—adrenal gland—germ cell cancer	0.00235	0.0173	CbGeAlD
Gliclazide—ABCC8—midbrain—germ cell cancer	0.00232	0.0171	CbGeAlD
Gliclazide—VEGFA—NOTCH1 regulation of human endothelial cell calcification—FGFR3—germ cell cancer	0.0023	0.0373	CbGpPWpGaD
Gliclazide—ABCC8—spinal cord—germ cell cancer	0.00226	0.0167	CbGeAlD
Gliclazide—VEGFA—brain—germ cell cancer	0.00221	0.0163	CbGeAlD
Gliclazide—KCNJ11—endocrine gland—germ cell cancer	0.00221	0.0163	CbGeAlD
Gliclazide—KCNJ11—head—germ cell cancer	0.00218	0.0161	CbGeAlD
Gliclazide—VEGFA—lymph node—germ cell cancer	0.00214	0.0158	CbGeAlD
Gliclazide—ABCC8—endocrine gland—germ cell cancer	0.00204	0.015	CbGeAlD
Gliclazide—ABCC8—head—germ cell cancer	0.00201	0.0148	CbGeAlD
Gliclazide—KCNJ11—cerebellum—germ cell cancer	0.00195	0.0144	CbGeAlD
Gliclazide—ABCC8—testis—germ cell cancer	0.00194	0.0143	CbGeAlD
Gliclazide—VEGFA—Platelet degranulation—CD9—germ cell cancer	0.00184	0.0299	CbGpPWpGaD
Gliclazide—ABCC8—cerebellum—germ cell cancer	0.00179	0.0132	CbGeAlD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.00175	0.0285	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—PHC1—germ cell cancer	0.00173	0.0281	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—ALPL—germ cell cancer	0.00172	0.0279	CbGpPWpGaD
Gliclazide—ALB—adrenal gland—germ cell cancer	0.00168	0.0124	CbGeAlD
Gliclazide—VEGFA—Differentiation Pathway—FGF4—germ cell cancer	0.00164	0.0266	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00163	0.0264	CbGpPWpGaD
Gliclazide—KCNJ11—brain—germ cell cancer	0.00158	0.0117	CbGeAlD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00157	0.0255	CbGpPWpGaD
Gliclazide—KCNJ11—lymph node—germ cell cancer	0.00153	0.0113	CbGeAlD
Gliclazide—ALB—Transport of organic anions—AVP—germ cell cancer	0.00151	0.0245	CbGpPWpGaD
Gliclazide—ABCC8—brain—germ cell cancer	0.00146	0.0108	CbGeAlD
Gliclazide—VEGFA—Bladder Cancer—FGFR3—germ cell cancer	0.00142	0.0231	CbGpPWpGaD
Gliclazide—ALB—testis—germ cell cancer	0.00139	0.0103	CbGeAlD
Gliclazide—VEGFA—Differentiation Pathway—KITLG—germ cell cancer	0.00135	0.0219	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.00118	0.0192	CbGpPWpGaD
Gliclazide—CYP2C19—endocrine gland—germ cell cancer	0.00117	0.00867	CbGeAlD
Gliclazide—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.00108	0.0175	CbGpPWpGaD
Gliclazide—ALB—brain—germ cell cancer	0.00104	0.0077	CbGeAlD
Gliclazide—ALB—lymph node—germ cell cancer	0.00101	0.00744	CbGeAlD
Gliclazide—VEGFA—Differentiation Pathway—KIT—germ cell cancer	0.000919	0.0149	CbGpPWpGaD
Gliclazide—CYP2C9—endocrine gland—germ cell cancer	0.00091	0.00672	CbGeAlD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00087	0.0141	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000817	0.0133	CbGpPWpGaD
Gliclazide—Agranulocytosis—Etoposide—germ cell cancer	0.000795	0.00179	CcSEcCtD
Gliclazide—VEGFA—Endochondral Ossification—FGFR3—germ cell cancer	0.000795	0.0129	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TDGF1—germ cell cancer	0.000795	0.0129	CbGpPWpGaD
Gliclazide—Thrombocytopenia—Bleomycin—germ cell cancer	0.000789	0.00177	CcSEcCtD
Gliclazide—Feeling abnormal—Vinblastine—germ cell cancer	0.000786	0.00177	CcSEcCtD
Gliclazide—Myalgia—Dactinomycin—germ cell cancer	0.000784	0.00176	CcSEcCtD
Gliclazide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000783	0.00176	CcSEcCtD
Gliclazide—Eye disorder—Cisplatin—germ cell cancer	0.000781	0.00176	CcSEcCtD
Gliclazide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00078	0.00175	CcSEcCtD
Gliclazide—Anaemia—Ifosfamide—germ cell cancer	0.00078	0.00175	CcSEcCtD
Gliclazide—Tinnitus—Cisplatin—germ cell cancer	0.000779	0.00175	CcSEcCtD
Gliclazide—Flushing—Cisplatin—germ cell cancer	0.000775	0.00174	CcSEcCtD
Gliclazide—Agitation—Ifosfamide—germ cell cancer	0.000775	0.00174	CcSEcCtD
Gliclazide—Discomfort—Dactinomycin—germ cell cancer	0.000774	0.00174	CcSEcCtD
Gliclazide—Angioedema—Ifosfamide—germ cell cancer	0.000771	0.00173	CcSEcCtD
Gliclazide—Thrombophlebitis—Methotrexate—germ cell cancer	0.000765	0.00172	CcSEcCtD
Gliclazide—Hypoaesthesia—Etoposide—germ cell cancer	0.000761	0.00171	CcSEcCtD
Gliclazide—Malaise—Ifosfamide—germ cell cancer	0.000761	0.00171	CcSEcCtD
Gliclazide—Leukopenia—Ifosfamide—germ cell cancer	0.000755	0.0017	CcSEcCtD
Gliclazide—Photosensitivity—Methotrexate—germ cell cancer	0.000755	0.0017	CcSEcCtD
Gliclazide—Polyuria—Methotrexate—germ cell cancer	0.000755	0.0017	CcSEcCtD
Gliclazide—Abdominal pain—Vinblastine—germ cell cancer	0.000754	0.0017	CcSEcCtD
Gliclazide—Hypotension—Bleomycin—germ cell cancer	0.000753	0.00169	CcSEcCtD
Gliclazide—Infection—Dactinomycin—germ cell cancer	0.000746	0.00168	CcSEcCtD
Gliclazide—Arrhythmia—Cisplatin—germ cell cancer	0.000746	0.00168	CcSEcCtD
Gliclazide—Palpitations—Ifosfamide—germ cell cancer	0.000745	0.00168	CcSEcCtD
Gliclazide—Hepatic failure—Methotrexate—germ cell cancer	0.000737	0.00166	CcSEcCtD
Gliclazide—Cough—Ifosfamide—germ cell cancer	0.000736	0.00166	CcSEcCtD
Gliclazide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000735	0.00165	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000734	0.00165	CcSEcCtD
Gliclazide—Convulsion—Ifosfamide—germ cell cancer	0.000731	0.00164	CcSEcCtD
Gliclazide—Hypertension—Ifosfamide—germ cell cancer	0.000728	0.00164	CcSEcCtD
Gliclazide—Erythema—Cisplatin—germ cell cancer	0.000727	0.00164	CcSEcCtD
Gliclazide—Malnutrition—Cisplatin—germ cell cancer	0.000727	0.00164	CcSEcCtD
Gliclazide—Erythema multiforme—Etoposide—germ cell cancer	0.000724	0.00163	CcSEcCtD
Gliclazide—Paraesthesia—Bleomycin—germ cell cancer	0.000723	0.00163	CcSEcCtD
Gliclazide—Dyspnoea—Bleomycin—germ cell cancer	0.000718	0.00162	CcSEcCtD
Gliclazide—Myalgia—Ifosfamide—germ cell cancer	0.000718	0.00162	CcSEcCtD
Gliclazide—Arthralgia—Ifosfamide—germ cell cancer	0.000718	0.00162	CcSEcCtD
Gliclazide—Chest pain—Ifosfamide—germ cell cancer	0.000718	0.00162	CcSEcCtD
Gliclazide—Renal failure acute—Methotrexate—germ cell cancer	0.000718	0.00161	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—MYC—germ cell cancer	0.000718	0.0116	CbGpPWpGaD
Gliclazide—Flatulence—Cisplatin—germ cell cancer	0.000717	0.00161	CcSEcCtD
Gliclazide—Eye disorder—Etoposide—germ cell cancer	0.000715	0.00161	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000713	0.0016	CcSEcCtD
Gliclazide—Flushing—Etoposide—germ cell cancer	0.00071	0.0016	CcSEcCtD
Gliclazide—Discomfort—Ifosfamide—germ cell cancer	0.000709	0.0016	CcSEcCtD
Gliclazide—Hypersensitivity—Vinblastine—germ cell cancer	0.000703	0.00158	CcSEcCtD
Gliclazide—Visual disturbance—Methotrexate—germ cell cancer	0.000699	0.00157	CcSEcCtD
Gliclazide—Confusional state—Ifosfamide—germ cell cancer	0.000694	0.00156	CcSEcCtD
Gliclazide—Pain—Bleomycin—germ cell cancer	0.000689	0.00155	CcSEcCtD
Gliclazide—Chills—Etoposide—germ cell cancer	0.000687	0.00155	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000684	0.00154	CcSEcCtD
Gliclazide—Asthenia—Vinblastine—germ cell cancer	0.000684	0.00154	CcSEcCtD
Gliclazide—Infection—Ifosfamide—germ cell cancer	0.000684	0.00154	CcSEcCtD
Gliclazide—Tremor—Cisplatin—germ cell cancer	0.000681	0.00153	CcSEcCtD
Gliclazide—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000676	0.00152	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—SALL4—germ cell cancer	0.000676	0.011	CbGpPWpGaD
Gliclazide—Nervous system disorder—Ifosfamide—germ cell cancer	0.000675	0.00152	CcSEcCtD
Gliclazide—Ill-defined disorder—Cisplatin—germ cell cancer	0.000675	0.00152	CcSEcCtD
Gliclazide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000674	0.00152	CcSEcCtD
Gliclazide—Anaemia—Cisplatin—germ cell cancer	0.000672	0.00151	CcSEcCtD
Gliclazide—Skin disorder—Ifosfamide—germ cell cancer	0.000669	0.0015	CcSEcCtD
Gliclazide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000665	0.0015	CcSEcCtD
Gliclazide—Feeling abnormal—Bleomycin—germ cell cancer	0.000664	0.00149	CcSEcCtD
Gliclazide—Osteoarthritis—Methotrexate—germ cell cancer	0.000663	0.00149	CcSEcCtD
Gliclazide—Malaise—Cisplatin—germ cell cancer	0.000656	0.00148	CcSEcCtD
Gliclazide—Diarrhoea—Vinblastine—germ cell cancer	0.000652	0.00147	CcSEcCtD
Gliclazide—Leukopenia—Cisplatin—germ cell cancer	0.000651	0.00146	CcSEcCtD
Gliclazide—ALB—Platelet degranulation—CD9—germ cell cancer	0.00065	0.0105	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NANOG—germ cell cancer	0.000648	0.0105	CbGpPWpGaD
Gliclazide—Fatigue—Dactinomycin—germ cell cancer	0.000648	0.00146	CcSEcCtD
Gliclazide—Back pain—Etoposide—germ cell cancer	0.000644	0.00145	CcSEcCtD
Gliclazide—Hypotension—Ifosfamide—germ cell cancer	0.000643	0.00145	CcSEcCtD
Gliclazide—Pain—Dactinomycin—germ cell cancer	0.000642	0.00145	CcSEcCtD
Gliclazide—Urticaria—Bleomycin—germ cell cancer	0.00064	0.00144	CcSEcCtD
Gliclazide—Body temperature increased—Bleomycin—germ cell cancer	0.000637	0.00143	CcSEcCtD
Gliclazide—Dizziness—Vinblastine—germ cell cancer	0.000631	0.00142	CcSEcCtD
Gliclazide—Convulsion—Cisplatin—germ cell cancer	0.00063	0.00142	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000628	0.0102	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000627	0.00141	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—POU5F1—germ cell cancer	0.000624	0.0101	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000619	0.0101	CbGpPWpGaD
Gliclazide—Myalgia—Cisplatin—germ cell cancer	0.000619	0.00139	CcSEcCtD
Gliclazide—Feeling abnormal—Dactinomycin—germ cell cancer	0.000619	0.00139	CcSEcCtD
Gliclazide—Paraesthesia—Ifosfamide—germ cell cancer	0.000618	0.00139	CcSEcCtD
Gliclazide—Ill-defined disorder—Etoposide—germ cell cancer	0.000618	0.00139	CcSEcCtD
Gliclazide—Anxiety—Cisplatin—germ cell cancer	0.000617	0.00139	CcSEcCtD
Gliclazide—Anaemia—Etoposide—germ cell cancer	0.000616	0.00139	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000615	0.00138	CcSEcCtD
Gliclazide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000614	0.00138	CcSEcCtD
Gliclazide—Dyspnoea—Ifosfamide—germ cell cancer	0.000614	0.00138	CcSEcCtD
Gliclazide—Somnolence—Ifosfamide—germ cell cancer	0.000612	0.00138	CcSEcCtD
Gliclazide—Discomfort—Cisplatin—germ cell cancer	0.000612	0.00138	CcSEcCtD
Gliclazide—Vomiting—Vinblastine—germ cell cancer	0.000606	0.00136	CcSEcCtD
Gliclazide—Malaise—Etoposide—germ cell cancer	0.000601	0.00135	CcSEcCtD
Gliclazide—Headache—Vinblastine—germ cell cancer	0.000597	0.00134	CcSEcCtD
Gliclazide—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000597	0.00134	CcSEcCtD
Gliclazide—Leukopenia—Etoposide—germ cell cancer	0.000596	0.00134	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000594	0.00134	CcSEcCtD
Gliclazide—Abdominal pain—Dactinomycin—germ cell cancer	0.000594	0.00134	CcSEcCtD
Gliclazide—Body temperature increased—Dactinomycin—germ cell cancer	0.000594	0.00134	CcSEcCtD
Gliclazide—Fatigue—Ifosfamide—germ cell cancer	0.000593	0.00134	CcSEcCtD
Gliclazide—Hypersensitivity—Bleomycin—germ cell cancer	0.000593	0.00134	CcSEcCtD
Gliclazide—Infection—Cisplatin—germ cell cancer	0.00059	0.00133	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—TP53—germ cell cancer	0.000589	0.00956	CbGpPWpGaD
Gliclazide—Constipation—Ifosfamide—germ cell cancer	0.000589	0.00132	CcSEcCtD
Gliclazide—Pain—Ifosfamide—germ cell cancer	0.000589	0.00132	CcSEcCtD
Gliclazide—Loss of consciousness—Etoposide—germ cell cancer	0.000585	0.00132	CcSEcCtD
Gliclazide—Nervous system disorder—Cisplatin—germ cell cancer	0.000582	0.00131	CcSEcCtD
Gliclazide—Cough—Etoposide—germ cell cancer	0.000581	0.00131	CcSEcCtD
Gliclazide—Thrombocytopenia—Cisplatin—germ cell cancer	0.000581	0.00131	CcSEcCtD
Gliclazide—Tachycardia—Cisplatin—germ cell cancer	0.000579	0.0013	CcSEcCtD
Gliclazide—Asthenia—Bleomycin—germ cell cancer	0.000578	0.0013	CcSEcCtD
Gliclazide—Convulsion—Etoposide—germ cell cancer	0.000577	0.0013	CcSEcCtD
Gliclazide—Skin disorder—Cisplatin—germ cell cancer	0.000576	0.0013	CcSEcCtD
Gliclazide—Hypertension—Etoposide—germ cell cancer	0.000575	0.00129	CcSEcCtD
Gliclazide—Hyperhidrosis—Cisplatin—germ cell cancer	0.000574	0.00129	CcSEcCtD
Gliclazide—Asthma—Methotrexate—germ cell cancer	0.000573	0.00129	CcSEcCtD
Gliclazide—Pruritus—Bleomycin—germ cell cancer	0.00057	0.00128	CcSEcCtD
Gliclazide—Feeling abnormal—Ifosfamide—germ cell cancer	0.000567	0.00128	CcSEcCtD
Gliclazide—Chest pain—Etoposide—germ cell cancer	0.000567	0.00128	CcSEcCtD
Gliclazide—Nausea—Vinblastine—germ cell cancer	0.000566	0.00127	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—HRAS—germ cell cancer	0.000564	0.00915	CbGpPWpGaD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000563	0.00127	CcSEcCtD
Gliclazide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000563	0.00127	CcSEcCtD
Gliclazide—Discomfort—Etoposide—germ cell cancer	0.00056	0.00126	CcSEcCtD
Gliclazide—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00056	0.00909	CbGpPWpGaD
Gliclazide—Hypotension—Cisplatin—germ cell cancer	0.000555	0.00125	CcSEcCtD
Gliclazide—Hypersensitivity—Dactinomycin—germ cell cancer	0.000553	0.00125	CcSEcCtD
Gliclazide—Abdominal discomfort—Methotrexate—germ cell cancer	0.000549	0.00124	CcSEcCtD
Gliclazide—Confusional state—Etoposide—germ cell cancer	0.000548	0.00123	CcSEcCtD
Gliclazide—Urticaria—Ifosfamide—germ cell cancer	0.000547	0.00123	CcSEcCtD
Gliclazide—Body temperature increased—Ifosfamide—germ cell cancer	0.000544	0.00122	CcSEcCtD
Gliclazide—Abdominal pain—Ifosfamide—germ cell cancer	0.000544	0.00122	CcSEcCtD
Gliclazide—Pancytopenia—Methotrexate—germ cell cancer	0.000544	0.00122	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000541	0.00122	CcSEcCtD
Gliclazide—Infection—Etoposide—germ cell cancer	0.00054	0.00122	CcSEcCtD
Gliclazide—Asthenia—Dactinomycin—germ cell cancer	0.000539	0.00121	CcSEcCtD
Gliclazide—Paraesthesia—Cisplatin—germ cell cancer	0.000533	0.0012	CcSEcCtD
Gliclazide—Thrombocytopenia—Etoposide—germ cell cancer	0.000532	0.0012	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000532	0.0012	CcSEcCtD
Gliclazide—Tachycardia—Etoposide—germ cell cancer	0.000531	0.00119	CcSEcCtD
Gliclazide—Dyspnoea—Cisplatin—germ cell cancer	0.000529	0.00119	CcSEcCtD
Gliclazide—Skin disorder—Etoposide—germ cell cancer	0.000528	0.00119	CcSEcCtD
Gliclazide—Erectile dysfunction—Methotrexate—germ cell cancer	0.000527	0.00119	CcSEcCtD
Gliclazide—Hyperhidrosis—Etoposide—germ cell cancer	0.000526	0.00118	CcSEcCtD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—HRAS—germ cell cancer	0.000523	0.0085	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000523	0.00849	CbGpPWpGaD
Gliclazide—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000523	0.00118	CcSEcCtD
Gliclazide—Diarrhoea—Dactinomycin—germ cell cancer	0.000514	0.00116	CcSEcCtD
Gliclazide—Pneumonia—Methotrexate—germ cell cancer	0.000514	0.00116	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000513	0.00832	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000512	0.00115	CcSEcCtD
Gliclazide—Vomiting—Bleomycin—germ cell cancer	0.000512	0.00115	CcSEcCtD
Gliclazide—Drowsiness—Methotrexate—germ cell cancer	0.000511	0.00115	CcSEcCtD
Gliclazide—Depression—Methotrexate—germ cell cancer	0.000509	0.00115	CcSEcCtD
Gliclazide—Hypotension—Etoposide—germ cell cancer	0.000508	0.00114	CcSEcCtD
Gliclazide—Rash—Bleomycin—germ cell cancer	0.000508	0.00114	CcSEcCtD
Gliclazide—Pain—Cisplatin—germ cell cancer	0.000507	0.00114	CcSEcCtD
Gliclazide—Dermatitis—Bleomycin—germ cell cancer	0.000507	0.00114	CcSEcCtD
Gliclazide—Hypersensitivity—Ifosfamide—germ cell cancer	0.000507	0.00114	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000506	0.00114	CcSEcCtD
Gliclazide—Renal failure—Methotrexate—germ cell cancer	0.000502	0.00113	CcSEcCtD
Gliclazide—Conjunctivitis—Methotrexate—germ cell cancer	0.000496	0.00112	CcSEcCtD
Gliclazide—Asthenia—Ifosfamide—germ cell cancer	0.000494	0.00111	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—KLF4—germ cell cancer	0.000491	0.00797	CbGpPWpGaD
Gliclazide—Sweating—Methotrexate—germ cell cancer	0.00049	0.0011	CcSEcCtD
Gliclazide—Feeling abnormal—Cisplatin—germ cell cancer	0.000489	0.0011	CcSEcCtD
Gliclazide—Paraesthesia—Etoposide—germ cell cancer	0.000488	0.0011	CcSEcCtD
Gliclazide—Pruritus—Ifosfamide—germ cell cancer	0.000487	0.0011	CcSEcCtD
Gliclazide—Dyspnoea—Etoposide—germ cell cancer	0.000485	0.00109	CcSEcCtD
Gliclazide—Somnolence—Etoposide—germ cell cancer	0.000483	0.00109	CcSEcCtD
Gliclazide—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000483	0.00109	CcSEcCtD
Gliclazide—Epistaxis—Methotrexate—germ cell cancer	0.000482	0.00108	CcSEcCtD
Gliclazide—Nausea—Bleomycin—germ cell cancer	0.000478	0.00108	CcSEcCtD
Gliclazide—Vomiting—Dactinomycin—germ cell cancer	0.000478	0.00107	CcSEcCtD
Gliclazide—Agranulocytosis—Methotrexate—germ cell cancer	0.000476	0.00107	CcSEcCtD
Gliclazide—Rash—Dactinomycin—germ cell cancer	0.000474	0.00107	CcSEcCtD
Gliclazide—Diarrhoea—Ifosfamide—germ cell cancer	0.000471	0.00106	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000469	0.00106	CcSEcCtD
Gliclazide—Body temperature increased—Cisplatin—germ cell cancer	0.000469	0.00106	CcSEcCtD
Gliclazide—Fatigue—Etoposide—germ cell cancer	0.000469	0.00105	CcSEcCtD
Gliclazide—Pain—Etoposide—germ cell cancer	0.000465	0.00105	CcSEcCtD
Gliclazide—Constipation—Etoposide—germ cell cancer	0.000465	0.00105	CcSEcCtD
Gliclazide—Hepatitis—Methotrexate—germ cell cancer	0.000458	0.00103	CcSEcCtD
Gliclazide—Dizziness—Ifosfamide—germ cell cancer	0.000455	0.00102	CcSEcCtD
Gliclazide—Pharyngitis—Methotrexate—germ cell cancer	0.000455	0.00102	CcSEcCtD
Gliclazide—Feeling abnormal—Etoposide—germ cell cancer	0.000448	0.00101	CcSEcCtD
Gliclazide—Nausea—Dactinomycin—germ cell cancer	0.000446	0.001	CcSEcCtD
Gliclazide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000445	0.001	CcSEcCtD
Gliclazide—Visual impairment—Methotrexate—germ cell cancer	0.000442	0.000994	CcSEcCtD
Gliclazide—Vomiting—Ifosfamide—germ cell cancer	0.000438	0.000985	CcSEcCtD
Gliclazide—Hypersensitivity—Cisplatin—germ cell cancer	0.000437	0.000984	CcSEcCtD
Gliclazide—Rash—Ifosfamide—germ cell cancer	0.000434	0.000977	CcSEcCtD
Gliclazide—Dermatitis—Ifosfamide—germ cell cancer	0.000434	0.000976	CcSEcCtD
Gliclazide—Erythema multiforme—Methotrexate—germ cell cancer	0.000433	0.000975	CcSEcCtD
Gliclazide—Urticaria—Etoposide—germ cell cancer	0.000432	0.000972	CcSEcCtD
Gliclazide—Body temperature increased—Etoposide—germ cell cancer	0.00043	0.000967	CcSEcCtD
Gliclazide—Abdominal pain—Etoposide—germ cell cancer	0.00043	0.000967	CcSEcCtD
Gliclazide—Eye disorder—Methotrexate—germ cell cancer	0.000428	0.000964	CcSEcCtD
Gliclazide—Tinnitus—Methotrexate—germ cell cancer	0.000427	0.000962	CcSEcCtD
Gliclazide—Asthenia—Cisplatin—germ cell cancer	0.000426	0.000958	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—CD9—germ cell cancer	0.000421	0.00683	CbGpPWpGaD
Gliclazide—Chills—Methotrexate—germ cell cancer	0.000411	0.000925	CcSEcCtD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000411	0.00667	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000411	0.00667	CbGpPWpGaD
Gliclazide—Nausea—Ifosfamide—germ cell cancer	0.000409	0.00092	CcSEcCtD
Gliclazide—Diarrhoea—Cisplatin—germ cell cancer	0.000406	0.000914	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000405	0.00657	CbGpPWpGaD
Gliclazide—Mental disorder—Methotrexate—germ cell cancer	0.000402	0.000904	CcSEcCtD
Gliclazide—Hypersensitivity—Etoposide—germ cell cancer	0.000401	0.000901	CcSEcCtD
Gliclazide—Erythema—Methotrexate—germ cell cancer	0.000399	0.000898	CcSEcCtD
Gliclazide—Malnutrition—Methotrexate—germ cell cancer	0.000399	0.000898	CcSEcCtD
Gliclazide—Asthenia—Etoposide—germ cell cancer	0.00039	0.000878	CcSEcCtD
Gliclazide—Back pain—Methotrexate—germ cell cancer	0.000386	0.000868	CcSEcCtD
Gliclazide—Pruritus—Etoposide—germ cell cancer	0.000385	0.000866	CcSEcCtD
Gliclazide—Vomiting—Cisplatin—germ cell cancer	0.000377	0.000849	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—H2AFZ—germ cell cancer	0.000374	0.00608	CbGpPWpGaD
Gliclazide—Rash—Cisplatin—germ cell cancer	0.000374	0.000842	CcSEcCtD
Gliclazide—Dermatitis—Cisplatin—germ cell cancer	0.000374	0.000841	CcSEcCtD
Gliclazide—Diarrhoea—Etoposide—germ cell cancer	0.000372	0.000837	CcSEcCtD
Gliclazide—Ill-defined disorder—Methotrexate—germ cell cancer	0.00037	0.000833	CcSEcCtD
Gliclazide—Anaemia—Methotrexate—germ cell cancer	0.000369	0.00083	CcSEcCtD
Gliclazide—Malaise—Methotrexate—germ cell cancer	0.00036	0.00081	CcSEcCtD
Gliclazide—Dizziness—Etoposide—germ cell cancer	0.00036	0.000809	CcSEcCtD
Gliclazide—Leukopenia—Methotrexate—germ cell cancer	0.000357	0.000804	CcSEcCtD
Gliclazide—Nausea—Cisplatin—germ cell cancer	0.000352	0.000793	CcSEcCtD
Gliclazide—Cough—Methotrexate—germ cell cancer	0.000348	0.000783	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—SOX2—germ cell cancer	0.000346	0.00562	CbGpPWpGaD
Gliclazide—Convulsion—Methotrexate—germ cell cancer	0.000346	0.000778	CcSEcCtD
Gliclazide—Vomiting—Etoposide—germ cell cancer	0.000346	0.000778	CcSEcCtD
Gliclazide—Rash—Etoposide—germ cell cancer	0.000343	0.000771	CcSEcCtD
Gliclazide—Dermatitis—Etoposide—germ cell cancer	0.000342	0.000771	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—HRAS—germ cell cancer	0.000341	0.00554	CbGpPWpGaD
Gliclazide—Headache—Etoposide—germ cell cancer	0.000341	0.000766	CcSEcCtD
Gliclazide—Arthralgia—Methotrexate—germ cell cancer	0.00034	0.000764	CcSEcCtD
Gliclazide—Myalgia—Methotrexate—germ cell cancer	0.00034	0.000764	CcSEcCtD
Gliclazide—Chest pain—Methotrexate—germ cell cancer	0.00034	0.000764	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000337	0.000759	CcSEcCtD
Gliclazide—Discomfort—Methotrexate—germ cell cancer	0.000336	0.000755	CcSEcCtD
Gliclazide—Confusional state—Methotrexate—germ cell cancer	0.000328	0.000739	CcSEcCtD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000326	0.00529	CbGpPWpGaD
Gliclazide—Infection—Methotrexate—germ cell cancer	0.000324	0.000728	CcSEcCtD
Gliclazide—Nausea—Etoposide—germ cell cancer	0.000323	0.000727	CcSEcCtD
Gliclazide—Nervous system disorder—Methotrexate—germ cell cancer	0.000319	0.000719	CcSEcCtD
Gliclazide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000319	0.000717	CcSEcCtD
Gliclazide—Skin disorder—Methotrexate—germ cell cancer	0.000316	0.000712	CcSEcCtD
Gliclazide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000315	0.000708	CcSEcCtD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000312	0.00506	CbGpPWpGaD
Gliclazide—Hypotension—Methotrexate—germ cell cancer	0.000304	0.000685	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000297	0.000668	CcSEcCtD
Gliclazide—Insomnia—Methotrexate—germ cell cancer	0.000295	0.000663	CcSEcCtD
Gliclazide—Paraesthesia—Methotrexate—germ cell cancer	0.000292	0.000658	CcSEcCtD
Gliclazide—Dyspnoea—Methotrexate—germ cell cancer	0.00029	0.000653	CcSEcCtD
Gliclazide—Somnolence—Methotrexate—germ cell cancer	0.00029	0.000651	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000288	0.00468	CbGpPWpGaD
Gliclazide—Dyspepsia—Methotrexate—germ cell cancer	0.000287	0.000645	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000281	0.000633	CcSEcCtD
Gliclazide—Fatigue—Methotrexate—germ cell cancer	0.000281	0.000632	CcSEcCtD
Gliclazide—Pain—Methotrexate—germ cell cancer	0.000278	0.000627	CcSEcCtD
Gliclazide—Feeling abnormal—Methotrexate—germ cell cancer	0.000268	0.000604	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000266	0.000599	CcSEcCtD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000261	0.00423	CbGpPWpGaD
Gliclazide—Urticaria—Methotrexate—germ cell cancer	0.000259	0.000582	CcSEcCtD
Gliclazide—Body temperature increased—Methotrexate—germ cell cancer	0.000257	0.000579	CcSEcCtD
Gliclazide—Abdominal pain—Methotrexate—germ cell cancer	0.000257	0.000579	CcSEcCtD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000257	0.00417	CbGpPWpGaD
Gliclazide—Hypersensitivity—Methotrexate—germ cell cancer	0.00024	0.00054	CcSEcCtD
Gliclazide—Asthenia—Methotrexate—germ cell cancer	0.000234	0.000526	CcSEcCtD
Gliclazide—VEGFA—EPH-Ephrin signaling—HRAS—germ cell cancer	0.000232	0.00377	CbGpPWpGaD
Gliclazide—Pruritus—Methotrexate—germ cell cancer	0.00023	0.000518	CcSEcCtD
Gliclazide—Diarrhoea—Methotrexate—germ cell cancer	0.000223	0.000501	CcSEcCtD
Gliclazide—Dizziness—Methotrexate—germ cell cancer	0.000215	0.000485	CcSEcCtD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.000209	0.0034	CbGpPWpGaD
Gliclazide—Vomiting—Methotrexate—germ cell cancer	0.000207	0.000466	CcSEcCtD
Gliclazide—Rash—Methotrexate—germ cell cancer	0.000205	0.000462	CcSEcCtD
Gliclazide—Dermatitis—Methotrexate—germ cell cancer	0.000205	0.000462	CcSEcCtD
Gliclazide—Headache—Methotrexate—germ cell cancer	0.000204	0.000459	CcSEcCtD
Gliclazide—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000203	0.00329	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000202	0.00328	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—HRAS—germ cell cancer	0.000197	0.00321	CbGpPWpGaD
Gliclazide—Nausea—Methotrexate—germ cell cancer	0.000193	0.000435	CcSEcCtD
Gliclazide—ABCC8—Metabolism—SLC2A3—germ cell cancer	0.000192	0.00312	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SLC22A3—germ cell cancer	0.00019	0.00308	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—AVP—germ cell cancer	0.00019	0.00308	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC2A3—germ cell cancer	0.000187	0.00303	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC22A3—germ cell cancer	0.000184	0.00298	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000168	0.00272	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000166	0.0027	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CRABP1—germ cell cancer	0.000155	0.00251	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CRABP1—germ cell cancer	0.00015	0.00243	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CD9—germ cell cancer	0.000149	0.00241	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000138	0.00223	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000133	0.00215	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—HRAS—germ cell cancer	0.000132	0.00214	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000131	0.00212	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00012	0.00195	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—germ cell cancer	0.000114	0.00184	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000112	0.00182	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—HRAS—germ cell cancer	0.000106	0.00173	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—germ cell cancer	0.000106	0.00172	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—HRAS—germ cell cancer	0.000103	0.00167	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.0001	0.00163	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—OXT—germ cell cancer	9.89e-05	0.00161	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.16e-05	0.00149	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—HRAS—germ cell cancer	8.62e-05	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGF4—germ cell cancer	8.45e-05	0.00137	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—H2AFZ—germ cell cancer	7.54e-05	0.00122	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KITLG—germ cell cancer	6.94e-05	0.00113	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AVP—germ cell cancer	6.78e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—germ cell cancer	6.31e-05	0.00102	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC2A3—germ cell cancer	6.21e-05	0.00101	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—HRAS—germ cell cancer	6.15e-05	0.000999	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC22A3—germ cell cancer	6.11e-05	0.000992	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	6.11e-05	0.000992	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HRAS—germ cell cancer	6.04e-05	0.00098	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC2A3—germ cell cancer	5.57e-05	0.000904	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC22A3—germ cell cancer	5.49e-05	0.000891	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGFR3—germ cell cancer	5.16e-05	0.000837	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC2A3—germ cell cancer	5.08e-05	0.000825	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC22A3—germ cell cancer	5e-05	0.000812	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CRABP1—germ cell cancer	4.98e-05	0.000809	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KIT—germ cell cancer	4.73e-05	0.000769	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CRABP1—germ cell cancer	4.47e-05	0.000726	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CRABP1—germ cell cancer	4.08e-05	0.000662	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MYC—germ cell cancer	2.61e-05	0.000423	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—germ cell cancer	2.23e-05	0.000362	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—germ cell cancer	2.14e-05	0.000347	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HRAS—germ cell cancer	2.13e-05	0.000346	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HRAS—germ cell cancer	2.05e-05	0.000332	CbGpPWpGaD
